Related references
Note: Only part of the references are listed.Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer
Liyun Zheng et al.
PHARMACOLOGICAL RESEARCH (2022)
Oxidative Damage to Mitochondria Enhanced by Ionising Radiation and Gold Nanoparticles in Cancer Cells
Farnaz Tabatabaie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy
Boyi Niu et al.
BIOMATERIALS (2021)
FOXO3a protects glioma cells against temozolomide-induced DNA double strand breaks via promotion of BNIP3-mediated mitophagy
Chuan He et al.
ACTA PHARMACOLOGICA SINICA (2021)
Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
Ana Rita Pombo Antunes et al.
NATURE NEUROSCIENCE (2021)
Rapid tumor recurrence in a novel murine GBM surgical model is associated with Akt/PD-L1/vimentin signaling
Feng Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis
Kecheng Lei et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Fan Yang et al.
NATURE COMMUNICATIONS (2021)
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy
Eleni Panagioti et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Reprogramming the immunosuppressive microenvironment of IDH1 wild-type glioblastoma by blocking Wnt signaling between microglia and cancer cells
Dandan Fan et al.
ONCOIMMUNOLOGY (2021)
Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury
Lin-Li Lv et al.
CELL DEATH AND DIFFERENTIATION (2020)
The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice
Kunpeng Wu et al.
BLOOD (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment
Anaelle A. Dumas et al.
EMBO JOURNAL (2020)
Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma
M. Hope Robinson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
Surya Kant Tripathi et al.
PHARMACOLOGICAL RESEARCH (2020)
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
Jasneet Kaur Khalsa et al.
NATURE COMMUNICATIONS (2020)
Discovery of a dual inhibitor of NQO1 and GSTP1 for treating glioblastoma
Kecheng Lei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Tobias Weiss et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
Zening Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Mannose synergizes with chemoradiotherapy to cure cancer via metabolically targeting HIF-1 in a novel triple-negative glioblastoma mouse model
Feng Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems
Hui Wang et al.
CANCER LETTERS (2019)
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma
Sang-Soo Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Activity- based protein profiling reveals GSTO1 as the covalent target of piperlongumine and a promising target for combination therapy for cancer
Li Li et al.
CHEMICAL COMMUNICATIONS (2019)
PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
Xin Yao Qiu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Translational gap in ongoing clinical trials for glioma
Alecia Florence Guishard et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
Etienne Becht et al.
CLINICAL CANCER RESEARCH (2016)
Role of neurochemical navigation with 5-aminolevulinic acid during intraoperative MRI-guided resection of intracranial malignant gliomas
Shinobu Yamada et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2015)
Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization
Geming Lu et al.
NATURE COMMUNICATIONS (2015)
Glioma
Michael Weller et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Piperlongumine Inhibits Migration of Glioblastoma Cells via Activation of ROS-Dependent p38 and JNK Signaling Pathways
Qian Rong Liu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection
Johannes vom Berg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial
Christian Senft et al.
LANCET ONCOLOGY (2011)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4(+) T cell compartment without affecting regulatory T-cell function
Peter E. Fecci et al.
CLINICAL CANCER RESEARCH (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
